Abstract:Objective Explore anti-tumor effect of the antigen specific cytotoxic T lymphocytes(CTLs) induced by dendritic cells(DCs) transfected with total RNA of lung adenocarcinoma cell in nude mice bearing lung A549 cell line.Methods 1)DCs induced from the peripheral blood mononuclear cells were transfected with total RNA extracted from lung adenocarcinoma A549 cells through electroporation,and co-cultured with T cells to activate antigen specific CTLs.2)DCs were divided into three groups:total RNA-transfected DCs,PBS-transfected DCs and non-transfected DCs.The phenotypes of CTLs were analyzed by flow cytometry.T cell proliferation was judged by 3H-TdR incorporation assay.3)Establish nude mice model by lung A549 cell line.Tumor-loaded nude mice were inoculated with CTLs and tumor sizes and inhibitive rates of the 3 groups were compared.The expressions of Bax、Bcl-2、COX-2 and VEGF in tumor tissues were detected by immunohistochemistry and their mean optical density(MOD) were analyzed by using automatic image analysis system.Results 1)The CTLs by autologous T cells co-cultured with RNA-transfected DCs got a significant increase of the CD8+ expression(25.58±2.73)% higer than those of PBS-transfected DCs(26.10±1.76)% and non-transfected DCs(25.58± 2.73)%(P<0.05).2)RNA-transfected DCs can significantly stimulate autologous T cell proliferation.The counts per minute(CPM) of positive control、total RNA-transfected DCs、PBS-transfected DCs and non-transfected DCs groups were 17 105±130,7 759±493,2 611±161,2 248±332 respectively(P<0.05).3) The lung model was successfully constructed in nude mice.Transplanted tumor size of the RNA-transfected DCs group was(540±99)mm3 at the end of experiments and was significantly inhibited compared with the PBS-transfected DCs(1 572±147) mm3 and non-transfected DCs(2 043±395)mm3 groups(P<0.05).4)The inhibitive rates of RNA-transfected DCs and PBS-transfected DCs groups were 68.53% and 8.62% respectively.5) It was displayed that the expression of Bax was up-regulated(the MOD of RNA-transfected DCs group was 335±105),and the expressions of COX-2、Bcl-2 and VEGF were down-regulated in the RNA-transfected DCs group(the MODs were 146±47、122±33 and 128±58 respectively).Conclusion DC cells transfected with total RNA of lung adenocarcinoma cell can stimulate antigen specific CTLs,which inhibited the growth of lung adenocarcinoma transplanted tumors in nude mice,resulting in a statistical significant difference in comparing with the control groups.

P3.02c-049 Dendritic Cells Modified with Tumor-Associated Antigen Gene Demonstrate Enhanced Antitumor Effect Against Lung Cancer

Immunotherapy with Dendritic Cells Modified with Tumor-Associated Antigen Gene Demonstrates Enhanced Antitumor Effect Against Lung Cancer

More efficient induction of antitumor T cell immunity by exosomes from CD40L gene-modified lung tumor cells.

Combinational Pulsing of TAAs Enforces Dendritic Cell-Based Immunotherapy through T-Cell Proliferation and Interferon-γ Secretion in LLC1 Mouse Model

Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8 + CTL response by exosomes derived from IL-18 gene-modified CEA-positive tumor cells

Tumor Cell-associated Exosomes Robustly Elicit Anti-tumor Immune Responses through Modulating Dendritic Cell Vaccines in Lung Tumor

Antitumor activity of lentivirus-mediated interleukin -12 gene modified dendritic cells in human lung cancer in vitro

Enhanced Therapeutic Efficacy Of Tumor Rna-Pulsed Dendritic Cells After Genetic Modification With Lymphotactin

Superior Anti-Tumor Protection and Therapeutic Efficacy of Vaccination with Dendritic Cell/Tumor Cell Fusion Hybrids for Murine Lewis Lung Carcinoma

Lymphotactin Gene-Modified Bone Marrow Dendritic Cells Act As More Potent Adjuvants for Peptide Delivery to Induce Specific Antitumor Immunity

Dendritic cells loaded with apoptotic tumor cells in the treatment of lung cancer

Studies on the Enhancement of DC Vaccine to Mouse Lewis Lung Cancer by CpG Oligonucleotides

Induction of Antitumor Cytotoxic Lymphocytes Using Engineered Human Primary Blood Dendritic Cells.

Antitumor Effect of Lung Cancer Vaccine with Umbilical Blood Dendritic Cells in Reconstituted Scid Mice

B-106 Development of Anti-Tumor Cytotoxic Lymphocytes Using Engineered Human Primary Blood Dendritic Cells

Endostatin Enhances Antitumor Effect of Tumor Antigen-Pulsed Dendritic Cell Therapy in Mouse Xenograft Model of Lung Carcinoma

Anti-tumor Activity of Dendritic Cells Loading in Situ Tumor Lysate Antigen Proudced by Radiofrequency Ablation

Anti-tumor effect of the antigen specific CTLs induced by dendritic cells transfected with total RNA of lung adenocarcinoma cell in vivo

Myeloid and Plasmacytoid Dendritic Cell Combined Vaccines Loaded with Heat-Treated Tumor Cell Lysates Enhance Antitumor Activity in Murine Lung Cancer

Tumor-associated Antigen-Based Personalized Dendritic Cell Vaccine in Solid Tumor Patients.

Personalized tumor antigen-pulsed dendritic cell therapy synergizes with simultaneous blockade of PD-1/TIM-3 to treat lung cancer